We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+8.16%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.15B
AUM Growth
+$69.3M
Cap. Flow
-$10.5M
Cap. Flow %
-0.92%
Top 10 Hldgs %
23.9%
Holding
286
New
11
Increased
62
Reduced
180
Closed
4

Top Sells

Rank Stock Value
1
MZTI
The Marzetti Company
MZTI
+$962K
2
CELG
Celgene Corp
CELG
+$866K
3
AAPL icon
Apple
AAPL
+$693K
4
DXCM icon
DexCom
DXCM
+$608K
5
O icon
Realty Income
O
+$568K

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.35%
2 Healthcare 13.71%
3 Technology 13.59%
4 Financials 11.8%
5 Consumer Staples 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
101
Target
TGT
$74.1B
$3.36M 0.29%
38,122
-8
-0% -$665
PNC icon
102
PNC Financial Services
PNC
$96.6B
$3.26M 0.28%
23,949
+35
+0.1% +$4.98K
IVV icon
103
iShares Core S&P 500 ETF
IVV
$898B
$3.23M 0.28%
11,038
-521
-5% -$149K
INTU icon
104
Intuit
INTU
$97.9B
$3.21M 0.28%
14,126
-519
-4% -$112K
VBR icon
105
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$3.12M 0.27%
22,370
-5
-0% -$701
YUM icon
106
Yum! Brands
YUM
$42B
$3.09M 0.27%
33,959
-1,672
-5% -$140K
CELG
107
DELISTED
Celgene Corp
CELG
$3.08M 0.27%
34,382
-9,804
-22% -$866K
NOC icon
108
Northrop Grumman
NOC
$77.5B
$3.03M 0.26%
9,557
-100
-1% -$30.5K
AABA
109
DELISTED
Altaba Inc
AABA
$2.9M 0.25%
42,572
-225
-0.5% -$15.9K
EOG icon
110
EOG Resources
EOG
$75.2B
$2.83M 0.25%
22,171
-656
-3% -$79.7K
TMO icon
111
Thermo Fisher Scientific
TMO
$230B
$2.83M 0.25%
11,580
-36
-0.3% -$8.28K
VWO icon
112
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$2.79M 0.24%
68,154
+1,271
+2% +$53.5K
BIIB icon
113
Biogen
BIIB
$32.3B
$2.79M 0.24%
7,902
+3
+0% +$1.03K
ITW icon
114
Illinois Tool Works
ITW
$79.8B
$2.78M 0.24%
19,724
-311
-2% -$43.8K
TFCFA
115
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$2.74M 0.24%
59,217
+270
+0.5% +$12.4K
CTSH icon
116
Cognizant
CTSH
$28.8B
$2.71M 0.24%
35,087
-250
-0.7% -$19.6K
LDOS icon
117
Leidos
LDOS
$17.7B
$2.68M 0.23%
38,714
GLW icon
118
Corning
GLW
$128B
$2.66M 0.23%
75,253
-2,590
-3% -$84.1K
EMB icon
119
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$2.63M 0.23%
24,387
+3,130
+15% +$336K
VEA icon
120
Vanguard FTSE Developed Markets ETF
VEA
$238B
$2.6M 0.23%
60,135
+4,600
+8% +$198K
KMB icon
121
Kimberly-Clark
KMB
$36.4B
$2.6M 0.23%
22,889
-590
-3% -$66.2K
BKNG icon
122
Booking.com
BKNG
$155B
$2.6M 0.23%
32,725
-400
-1% -$31.5K
BLK icon
123
Blackrock
BLK
$180B
$2.6M 0.23%
5,506
-56
-1% -$27.2K
ESRX
124
DELISTED
Express Scripts Holding Company
ESRX
$2.58M 0.23%
27,134
+818
+3% +$69.7K
EBAY icon
125
eBay
EBAY
$47B
$2.52M 0.22%
76,377
-1,586
-2% -$55K

Similar funds

Dowling & Yahnke's Q3 2018 Portfolio in Review

As of Q3 2018, Dowling & Yahnke held 286 positions worth $1.15B, up 6.4% from $1.08B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dowling & Yahnke's Q3 2018 filing shows 11 new, 62 increased, 180 reduced and 4 closed positions. Its largest new stake was Schwab Short-Term US Treasury ETF: 31,120 shares worth $771K. The largest sale was The Marzetti Company, an estimated $962K.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

  • Dowling & Yahnke's largest Q3 2018 buy was Schwab Short-Term US Treasury ETF: 31,120 shares worth $771K.
  • Dowling & Yahnke added most to Johnson & Johnson in Q3 2018, an estimated $1.56M increase.
  • Dowling & Yahnke's biggest Q3 2018 reduction was The Marzetti Company, cutting an estimated $962K.
  • Dowling & Yahnke fully exited McKesson in Q3 2018, selling an estimated $460K.
  • Dowling & Yahnke's ten largest holdings make up 24% of its $1.15B portfolio in Q3 2018.
  • Dowling & Yahnke opened 11 new positions and closed 4 in Q3 2018.
  • Dowling & Yahnke's portfolio value rose 6.4% quarter-over-quarter to $1.15B.

Based on Dowling & Yahnke's 13F filing for Q3 2018, filed 30 Oct 2018.